On August 3, MaxLinear fell 8.38% in pre-market trading, trading at approximately 62.44 USD/share, with turnover of 2.5234 million USD. The decline was driven by consecutive institutional selling and broad semiconductor sector weakness.

On the news front, BNY Mellon recently reduced its MaxLinear holdings, following an earlier sale by Manulife Insurance. The successive institutional exits have intensified selling pressure on the stock. MaxLinear had already retreated more than 20% from its post-earnings highs due to profit-taking, and a brief 5% rebound on July 31 failed to hold as selling resumed.

The broader semiconductor sector weighed heavily on sentiment, with Micron Technology down 4.62%, Advanced Micro Devices down 3.02%, Intel down 2.26%, NVIDIA down 1.84%, and Broadcom down 1.61%, further dragging MaxLinear into extended correction territory despite solid Q2 results that showed revenue of $168.8 million and adjusted EPS of $0.35, both above consensus, along with Q3 revenue guidance of $210-220 million far exceeding the $173.9 million estimate.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)